A novel tetramethylpyrazine derivative inhibits thyroid cancer progression by epigenetically suppressing DUSP19 to activate the JNK signaling pathway
Acta Biochimica et Biophysica Sinica · 01.11.2026 · 58 (11) · 2441-2458
DOI: 10.3724/abbs.2026022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, online erschienen am 08.05.2026. Verfasst von Pengfei Gu und 16 weiteren Autor:innen. Hauptthemen laut MEDLINE: Pyrazines, Thyroid Neoplasms, Epigenesis, Genetic, MAP Kinase Signaling System. Die Arbeit nennt 62 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Gu, P., Zeng, Y., Meng, S., Hao, W., Zhang, W., Wan, X., Liu, Y., Chi, J., Hu, L., Li, D., Zhao, J., Wei, S., Zhang, J., Liu, T., Ruan, X., Zheng, X., & Gao, M. (2026). A novel tetramethylpyrazine derivative inhibits thyroid cancer progression by epigenetically suppressing DUSP19 to activate the JNK signaling pathway. Acta Biochimica et Biophysica Sinica, 58(11), 2441-2458. https://doi.org/10.3724/abbs.2026022
Vancouver
Gu P, Zeng Y, Meng S, Hao W, Zhang W, Wan X, et al. A novel tetramethylpyrazine derivative inhibits thyroid cancer progression by epigenetically suppressing DUSP19 to activate the JNK signaling pathway. Acta Biochimica et Biophysica Sinica. 2026;58(11):2441-2458. doi:10.3724/abbs.2026022
BibTeX
@article{Gu2026,
author = {Gu, Pengfei and Zeng, Yu and Meng, Shuai and Hao, Weijing and Zhang, Wei and Wan, Xing and Liu, Yu and Chi, Jiadong and Hu, Linfei and Li, Dapeng and Zhao, Jingzhu and Wei, Songfeng and Zhang, Jie and Liu, Tianjun and Ruan, Xianhui and Zheng, Xiangqian and Gao, Ming},
title = {A novel tetramethylpyrazine derivative inhibits thyroid cancer progression by epigenetically suppressing DUSP19 to activate the JNK signaling pathway},
journal = {Acta Biochimica et Biophysica Sinica},
year = {2026},
volume = {58},
number = {11},
pages = {2441--2458},
doi = {10.3724/abbs.2026022}
}
EUVIMED